Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers

The assessment of EGFR mutations is recommended for the management of patients with non-small cell lung cancer (NSCLC). Presence of EGFR mutation is associated with response or resistance to EGFR tyrosine kinase inhibitors (EGFR-TKI). Liquid biopsy is nowadays widely used for the detection of resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilson, Pauline, Saurel, Chloé, Salleron, Julia, Husson, Marie, Demange, Jessica, Merlin, Jean-Louis, Harlé, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131701/
https://www.ncbi.nlm.nih.gov/pubmed/34006948
http://dx.doi.org/10.1038/s41598-021-90091-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131701/
https://www.ncbi.nlm.nih.gov/pubmed/34006948
http://dx.doi.org/10.1038/s41598-021-90091-z

Ejemplares similares